Update on the con­se­quen­ces of Brexit for the medi­cal devices industry

The United King­dom with­drew from the EU on 31 Janu­ary 2020, the fourth offi­ci­al with­dra­wal date. The drea­ded “Brexit” has now come to pass. The par­ties were able to avo­id a “hard” or “no-deal Brexit” for the time being: the With­dra­wal Agree­ment con­cluded bet­ween the EU and the United King­dom arran­ges the legal rela­ti­onships bet­ween the par­ties through the end of an 11-month tran­si­tio­nal peri­od expi­ring on 31 Decem­ber 2020. 

This peri­od may be exten­ded once by up to two years, i.e. through 31 Decem­ber 2022 at the latest. During this tran­si­tio­nal peri­od, the­re will be no radi­cal chan­ges for the medi­cal devices indus­try, as the United King­dom will con­ti­nue to be trea­ted as an EU mem­ber sta­te until the peri­od expi­res. This means that EU law will con­ti­nue to app­ly and the United King­dom will con­ti­nue to have all the rights and duties of a mem­ber state.

Howe­ver, it must be stres­sed that the With­dra­wal Agree­ment con­ta­ins pro­vi­si­ons about free move­ment of goods which are of signi­fi­can­ce for the medi­cal devices indus­try as well. For exam­p­le, the Agree­ment defi­nes pro­ce­du­res for the exch­an­ge of infor­ma­ti­on bet­ween noti­fied bodies in the EU and the United King­dom, which are refer­red to in the Agree­ment as “con­for­mi­ty assess­ment bodies.” This term is used not just for the limi­t­ed num­ber of estab­lished noti­fied bodies for medi­cal devices, but rather appli­es in a gene­ral man­ner to insti­tu­ti­ons which are aut­ho­ri­zed to con­duct con­for­mi­ty assess­ment pro­ce­du­res under EU law.

Ano­ther aspect of importance for manu­fac­tu­r­ers is that the With­dra­wal Agree­ment express­ly gua­ran­tees that devices which were lawful­ly pla­ced on the mar­ket pri­or to expi­ra­ti­on of the tran­si­tio­nal peri­od will be allo­wed to remain on the mar­ket even after the tran­si­tio­nal peri­od is over. This means that manu­fac­tu­r­ers and dis­tri­bu­tors of medi­cal devices can con­ti­nue to mar­ket and sell their medi­cal devices in both the EU and UK markets.

The impact which Brexit will have after the tran­si­tio­nal peri­od expi­res is still unclear. All we have so far is the “Poli­ti­cal Decla­ra­ti­on,” which con­ta­ins a rough sketch of the con­di­ti­ons for future coope­ra­ti­on bet­ween the EU and the United King­dom. This Decla­ra­ti­on allows for the cau­tious con­clu­si­on that the par­ties will keep regu­la­ted indus­tries like the medi­cal devices indus­try in mind and nego­tia­te the­se mat­ters exten­si­ve­ly in future agreements.

But if no via­ble agree­ment is rea­ched by the time the tran­si­tio­nal peri­od expi­res and the “no-deal Brexit” sce­na­rio ree­mer­ges ins­tead, the United King­dom would have to be trea­ted as a third coun­try, which could have a nega­ti­ve impact on the medi­cal devices indus­try, e.g. with respect to the vali­di­ty of exis­ting CE certificates.


Stay up-to-date

We use your email address exclusively for sending our newsletter. You have the right to revoke your consent at any time with effect for the future. For further information, please refer to our privacy policy.